Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
BNT-164 by BioNTech for Tuberculosis: Likelihood of Approval
BNT-164 is under clinical development by BioNTech and currently in Phase II for Tuberculosis. According to GlobalData, Phase II drugs...